Clinical Trials Directory

Trials / Completed

CompletedNCT00986024

Resistance and/or Endurance Training, What is Most Effective in Prevention of Cardiovascular Diseases?

Strength Training Versus Aerobic Interval Training to Modify Risk Factors of the Metabolic Syndrome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
31 (actual)
Sponsor
Norwegian University of Science and Technology · Academic / Other
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The aim of the present study was to evaluate the effects of aerobic interval training versus strength training or a combination of these regimes on factors comprising the metabolic syndrome in order to find the most effective exercise regime for patients with metabolic syndrome.

Detailed description

In the Western world, approximately 25% of young to middle-aged adults have metabolic syndrome. There seem to be a strong age-dependence in the prevalence of the metabolic syndrome, but the incidence rises rapidly within adolescents and middle-aged groups and follows the development of obesity in the general population. Metabolic syndrome confers an increased risk of coronary heart disease, cardiovascular disease, and premature death; therefore, effective and affordable strategies to combat the syndrome would be of great individual and social importance. Despite the general agreement that moderate-intensity physical activity for a minimum of 30 min five days per week or vigorous-intensity aerobic physical activity for a minimum of 20 min three days a week promote and maintain health, the optimal training regime to treat metabolic syndrome and its associated cardiovascular abnormalities remains uncertain.

Conditions

Interventions

TypeNameDescription
BEHAVIORALaerobic exercisecarried out 3 times per week for 12 weeks
BEHAVIORALstrength trainingcarried out 3 times per week for 12 weeks

Timeline

Start date
2006-08-01
Primary completion
2007-03-01
Completion
2007-03-01
First posted
2009-09-29
Last updated
2012-12-13

Source: ClinicalTrials.gov record NCT00986024. Inclusion in this directory is not an endorsement.